We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PXXLF market cap is 32.61M. The company's latest EPS is EUR -0.6740 and P/E is -0.79.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 78.16M | 30.93M | 6.81M | 13.4M | 674k |
| Operating Income | 12.54M | -24.67M | -29.82M | -22.46M | -21.89M |
| Net Income | 13.53M | -25.74M | -31.83M | -23.76M | -31.4M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 105.52M | 72.3M | 65.08M | 54.89M | 34.71M |
| Total Liabilities | 49.73M | 33.16M | 38.01M | 46.68M | 52.96M |
| Total Equity | 55.78M | 39.14M | 27.07M | 8.21M | -18.24M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -4.74M | -25.69M | -25.75M | -16.89M | -21.81M |
| Investing | -7.61M | 352k | 52k | -43k | N/A |
| Financing | 25.68M | -4.21M | 28.71M | 9.02M | 2.59M |
| Market Cap | 32.61M |
| Price to Earnings Ratio | -0.79 |
| Price to Sales Ratio | 36.55 |
| Price to Cash Ratio | 1.89 |
| Price to Book Ratio | -1.35 |
| Dividend Yield | - |
| Shares Outstanding | 46.59M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 1,000 |
| 52 Week Change | 16.67% |
| 52 Week High | 0.70 |
| 52 Week Low | 0.545 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Poxel SA (CE) |
| Address |
259/261 avenue jean jaures - immeuble le sunway lyon, rhone 69007 |
| Website | https://www.poxel.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
